featured
Intermittent Androgen Monotherapy Is Noninferior to Maximal Androgen Blockade for Advanced PCa
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Locally Advanced and Metastatic Prostate Cancer Treated With Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results From a Randomised Phase 3 Study by the South European Uroncological Group
Eur Urol 2014 Aug 01;66(1)232-239, FC Silva, FM Silva, F Gonçalves, A Santos, J Kliment, P Whelan, T Oliver, N Antoniou, S Pastidis, AM Queimadelos, C RobertsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.